Sell
Celldex Therapeutics (CLDX)
from Cabot Top Ten Trader, recommended at $22 in the August 2013 Investment Digest, issue 748.
We think the speculative biotech stocks have topped out for now, and favor selling Celldex. They can bounce, of course, but the selling pressures this week were very abnormal.
Michael Cintolo, Cabot Top Ten Trader, www.cabot.net, 978-745-5532, October 11, 2013